Literature DB >> 2837494

Effect of mutations affecting Na+: H+ antiport activity on tumorigenic potential of hamster lung fibroblasts.

A E Lagarde1, A J Franchi, S Paris, J M Pouysségur.   

Abstract

Mutants unable to regulate intracellular pH through the Na+: H+ antiport system were found to evolve tumors less frequently than wild-type CCL39 hamster lung fibroblasts, after transplantation in athymic nude mice. When rare tumors arose, they comprised cells which were transformed in vitro, but which upon retransplantation grew at a lower rate than tumor cells originating from CCL39 cells. Both parental and mutant cells became transformed after transfection of the activated Harvey ras oncogene, but transfectants derived from the mutants had a weaker tumorigenic potential. These results suggest that transformed characteristics can be acquired independently from the Na+: H+ antiporter. However, the presence of this system provides a selective growth advantage when cells are confronted with natural environments, as it occurs during the expansion of tumors in a host.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837494     DOI: 10.1002/jcb.240360306

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

1.  A unifying model of the cell proliferation emphasizing plasma membrane fluxes.

Authors:  E Cervén
Journal:  Experientia       Date:  1990-10-15

Review 2.  Neutral amino acid transport systems in animal cells: potential targets of oncogene action and regulators of cellular growth.

Authors:  M H Saier; G A Daniels; P Boerner; J Lin
Journal:  J Membr Biol       Date:  1988-08       Impact factor: 1.843

Review 3.  Tumour acidosis: from the passenger to the driver's seat.

Authors:  Cyril Corbet; Olivier Feron
Journal:  Nat Rev Cancer       Date:  2017-09-15       Impact factor: 60.716

Review 4.  Traditional and emerging roles for the SLC9 Na+/H+ exchangers.

Authors:  Daniel G Fuster; R Todd Alexander
Journal:  Pflugers Arch       Date:  2013-12-12       Impact factor: 3.657

Review 5.  Interfering with pH regulation in tumours as a therapeutic strategy.

Authors:  Dario Neri; Claudiu T Supuran
Journal:  Nat Rev Drug Discov       Date:  2011-09-16       Impact factor: 84.694

6.  Migration of human melanoma cells depends on extracellular pH and Na+/H+ exchange.

Authors:  Christian Stock; Birgit Gassner; Christof R Hauck; Hannelore Arnold; Sabine Mally; Johannes A Eble; Peter Dieterich; Albrecht Schwab
Journal:  J Physiol       Date:  2005-06-09       Impact factor: 5.182

Review 7.  Cancer cell behaviors mediated by dysregulated pH dynamics at a glance.

Authors:  Katharine A White; Bree K Grillo-Hill; Diane L Barber
Journal:  J Cell Sci       Date:  2017-02-15       Impact factor: 5.285

8.  K+/H+-antiporter nigericin arrests DNA synthesis in Ehrlich ascites carcinoma cells.

Authors:  L B Margolis; Y u Novikova I; I A Rozovskaya; V P Skulachev
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 9.  SLC9/NHE gene family, a plasma membrane and organellar family of Na⁺/H⁺ exchangers.

Authors:  Mark Donowitz; C Ming Tse; Daniel Fuster
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

10.  The target landscape of clinical kinase drugs.

Authors:  Susan Klaeger; Stephanie Heinzlmeir; Mathias Wilhelm; Harald Polzer; Binje Vick; Paul-Albert Koenig; Maria Reinecke; Benjamin Ruprecht; Svenja Petzoldt; Chen Meng; Jana Zecha; Katrin Reiter; Huichao Qiao; Dominic Helm; Heiner Koch; Melanie Schoof; Giulia Canevari; Elena Casale; Stefania Re Depaolini; Annette Feuchtinger; Zhixiang Wu; Tobias Schmidt; Lars Rueckert; Wilhelm Becker; Jan Huenges; Anne-Kathrin Garz; Bjoern-Oliver Gohlke; Daniel Paul Zolg; Gian Kayser; Tonu Vooder; Robert Preissner; Hannes Hahne; Neeme Tõnisson; Karl Kramer; Katharina Götze; Florian Bassermann; Judith Schlegl; Hans-Christian Ehrlich; Stephan Aiche; Axel Walch; Philipp A Greif; Sabine Schneider; Eduard Rudolf Felder; Juergen Ruland; Guillaume Médard; Irmela Jeremias; Karsten Spiekermann; Bernhard Kuster
Journal:  Science       Date:  2017-12-01       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.